Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 63,260 | -49,021 | -172,415 | -129,455 | -82,035 |
| Depreciation Amortization | 611 | 329 | 736 | 3,091 | 2,061 |
| Accounts receivable | N/A | N/A | N/A | -5,560 | -1,544 |
| Accounts payable and accrued liabilities | -860 | -502 | -1,062 | -1,476 | -6,503 |
| Other Working Capital | -10,736 | -2,380 | 4,591 | 5,026 | 6,035 |
| Other Operating Activity | -90,868 | 33,702 | 113,017 | 25,239 | 17,074 |
| Operating Cash Flow | $-38,593 | $-17,872 | $-55,133 | $-103,135 | $-64,912 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21 | -42 | -34 | -34 | -104 |
| Purchase Sale Intangibles | -267 | -170 | -2,189 | -675 | -423 |
| Other Investing Activity | -267 | -170 | -2,189 | -675 | -423 |
| Investing Cash Flow | $-288 | $-212 | $-2,223 | $-709 | $-527 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | N/A | 184,670 | 183,317 | 151,495 |
| Other Financing Activity | -125,000 | -5,000 | -55,118 | -55,118 | -55,118 |
| Financing Cash Flow | $-125,000 | $-5,000 | $129,552 | $128,199 | $96,377 |
| Beginning Cash Position | 65,122 | 65,122 | 80,486 | 80,486 | 80,486 |
| End Cash Position | 26,303 | 30,384 | 65,122 | 104,841 | 111,424 |
| Net Cash Flow | $-38,819 | $-34,738 | $-15,364 | $24,355 | $30,938 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,593 | -17,872 | -55,133 | -103,135 | -64,912 |
| Capital Expenditure | -21 | -42 | -34 | -34 | -104 |
| Free Cash Flow | -38,614 | -17,914 | -55,167 | -103,169 | -65,016 |